Why the study?
The impact of RV pacing and CRT in cardiac amyloidosis is not known.
Does cardiac resynchronization therapy improve LV systolic function and heart failure symptoms in patients with transthyretin amyloidosis who developed heart failure following right ventricular pacing?
Does cardiac resynchronization therapy improve LV systolic function and heart failure symptoms in patients with transthyretin amyloidosis who developed heart failure following right ventricular pacing?
Cardiac resynchronization therapy may reverse left ventricular systolic dysfunction and heart failure symptoms induced by right ventricular pacing in patients with transthyretin amyloidosis.
Answers are grounded in this paper and cite their sources.
CRT may rescue LVEF after RV pacing in ATTR; leaves open optimal device selection in amyloid cardiomyopathy.
BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). DISCUSSION: The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.
No takes yet. Share an insight, caveat, or question.
Aouate et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: